Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 11,890 | 2,831 | 24,741 | 7,543 | 3,578 |
| Gross Profit | 11,890 | 2,831 | 24,741 | 7,543 | 3,578 |
| Operating Expenses | 30,444 | 27,834 | 32,496 | 32,091 | 55,122 |
| Operating Income | -18,554 | -25,003 | -7,755 | -24,548 | -51,544 |
| Interest Expense | 1,061 | 1,072 | -464 | 2,399 | 2,020 |
| Other Income | 1,385 | 1,093 | 1,671 | 1,830 | 329 |
| Pre-tax Income | -18,230 | -24,982 | -5,620 | -25,117 | -53,235 |
| Net Income Continuous | -18,230 | -24,982 | -5,620 | -25,117 | -53,235 |
| Net Income | $-18,230 | $-24,982 | $-5,620 | $-25,117 | $-53,235 |
| EPS Basic Total Ops | -0.15 | -0.26 | 0.03 | -0.28 | -0.63 |
| EPS Basic Continuous Ops | -0.15 | -0.26 | 0.02 | -0.28 | -0.63 |
| EPS Diluted Total Ops | -0.15 | -0.26 | 0.03 | -0.28 | -0.63 |
| EPS Diluted Continuous Ops | -0.15 | -0.26 | 0.02 | -0.28 | -0.63 |
| EPS Diluted Before Non-Recurring Items | -0.15 | -0.26 | -0.06 | -0.28 | -0.63 |
| EBITDA(a) | $-18,280 | $-24,520 | $-6,950 | $-23,889 | $-49,967 |